Cryopreservation formulations
Cryopreservation formulations combining glycerol, trehalose, ascorbic acid, and taurine address the limitations of DMSO-based methods by enhancing cell survival and viability, providing an effective DMSO-free solution for preserving mammalian cells and tissues.
Patent Information
- Application Number
- PCT/US2024/038545
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-07-18
- Filing Date
- 2024-07-18
- Publication Date
- 2025-01-23
AI Technical Summary
Current cryopreservation methods using dimethyl sulfoxide (DMSO) as a cryoprotectant agent have drawbacks, including potential toxicity to cells, and existing DMSO-free alternatives may not be effective for all applications.
The development of cryopreservation formulations and media that utilize a combination of cryoprotective agents such as glycerol, trehalose, ascorbic acid, and taurine, without DMSO, to effectively preserve mammalian cells and tissues.
These formulations demonstrate improved cell survival and viability post-thawing compared to traditional methods, offering a DMSO-free alternative that is effective for cryopreserving a wide range of mammalian cells and tissues.
Smart Images

Figure IMGF000014_0001 
Figure IMGF000015_0001 
Figure IMGF000016_0001
Abstract
Citation Information
Patent Citations
Cryopreservation of stem cells
US20220104481A1
Cryopreservation and cell culture media
US20220159945A1
Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation
US20230097342A1
Composition comprising glass forming agent(s) for use as cryoprotectants and methods of making and using the same
WO2023064216A1
Cryopreservation compositions and methods using red blood cells
WO2023122672A1
Cited By
Lipid nanoparticle cryoprotectants
CN119746089A
Lipid nanoparticle cryoprotectant
CN119746089B